nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0187	0.0243	CbGbCtD
Verapamil—ABCC3—Lamivudine—acquired immunodeficiency syndrome	0.0171	0.0222	CbGbCtD
Verapamil—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.0169	0.0219	CbGbCtD
Verapamil—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0161	0.0209	CbGbCtD
Verapamil—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0144	0.0187	CbGbCtD
Verapamil—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0142	0.0184	CbGbCtD
Verapamil—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0142	0.0184	CbGbCtD
Verapamil—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.014	0.0182	CbGbCtD
Verapamil—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0136	0.0176	CbGbCtD
Verapamil—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.0171	CbGbCtD
Verapamil—ABCC4—Lamivudine—acquired immunodeficiency syndrome	0.0131	0.017	CbGbCtD
Verapamil—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0127	0.0165	CbGbCtD
Verapamil—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0126	0.0164	CbGbCtD
Verapamil—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0126	0.0164	CbGbCtD
Verapamil—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0123	0.016	CbGbCtD
Verapamil—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0119	0.0155	CbGbCtD
Verapamil—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0155	CbGbCtD
Verapamil—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0155	CbGbCtD
Verapamil—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0111	0.0145	CbGbCtD
Verapamil—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0105	0.0136	CbGbCtD
Verapamil—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0105	0.0136	CbGbCtD
Verapamil—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0105	0.0136	CbGbCtD
Verapamil—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0105	0.0136	CbGbCtD
Verapamil—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0103	0.0134	CbGbCtD
Verapamil—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.00972	0.0126	CbGbCtD
Verapamil—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.00972	0.0126	CbGbCtD
Verapamil—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.00947	0.0123	CbGbCtD
Verapamil—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.00947	0.0123	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.00923	0.012	CbGbCtD
Verapamil—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.00923	0.012	CbGbCtD
Verapamil—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.00908	0.0118	CbGbCtD
Verapamil—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.00879	0.0114	CbGbCtD
Verapamil—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.00827	0.0107	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.00797	0.0104	CbGbCtD
Verapamil—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.00797	0.0104	CbGbCtD
Verapamil—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.00777	0.0101	CbGbCtD
Verapamil—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.00774	0.0101	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.00774	0.0101	CbGbCtD
Verapamil—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00766	0.00995	CbGbCtD
Verapamil—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.00737	0.00957	CbGbCtD
Verapamil—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.00703	0.00913	CbGbCtD
Verapamil—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.007	0.00909	CbGbCtD
Verapamil—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.007	0.00909	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.007	0.00909	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.007	0.00909	CbGbCtD
Verapamil—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00693	0.009	CbGbCtD
Verapamil—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00693	0.009	CbGbCtD
Verapamil—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.00666	0.00866	CbGbCtD
Verapamil—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00666	0.00865	CbGbCtD
Verapamil—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00666	0.00865	CbGbCtD
Verapamil—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00657	0.00853	CbGbCtD
Verapamil—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00618	0.00802	CbGbCtD
Verapamil—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00606	0.00787	CbGbCtD
Verapamil—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00598	0.00777	CbGbCtD
Verapamil—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0058	0.00754	CbGbCtD
Verapamil—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0057	0.0074	CbGbCtD
Verapamil—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0057	0.0074	CbGbCtD
Verapamil—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00559	0.00726	CbGbCtD
Verapamil—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00559	0.00726	CbGbCtD
Verapamil—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00546	0.0071	CbGbCtD
Verapamil—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00525	0.00682	CbGbCtD
Verapamil—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00525	0.00682	CbGbCtD
Verapamil—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00515	0.0067	CbGbCtD
Verapamil—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00514	0.00667	CbGbCtD
Verapamil—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00514	0.00667	CbGbCtD
Verapamil—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00505	0.00656	CbGbCtD
Verapamil—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00505	0.00656	CbGbCtD
Verapamil—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.005	0.00649	CbGbCtD
Verapamil—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00498	0.00647	CbGbCtD
Verapamil—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00484	0.00628	CbGbCtD
Verapamil—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00482	0.00626	CbGbCtD
Verapamil—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0047	0.0061	CbGbCtD
Verapamil—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0047	0.0061	CbGbCtD
Verapamil—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00468	0.00608	CbGbCtD
Verapamil—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00464	0.00603	CbGbCtD
Verapamil—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00464	0.00603	CbGbCtD
Verapamil—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00451	0.00586	CbGbCtD
Verapamil—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00432	0.00561	CbGbCtD
Verapamil—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00425	0.00552	CbGbCtD
Verapamil—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00425	0.00552	CbGbCtD
Verapamil—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00423	0.0055	CbGbCtD
Verapamil—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00423	0.0055	CbGbCtD
Verapamil—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00406	0.00527	CbGbCtD
Verapamil—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00401	0.00521	CbGbCtD
Verapamil—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00391	0.00507	CbGbCtD
Verapamil—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00389	0.00506	CbGbCtD
Verapamil—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00389	0.00505	CbGbCtD
Verapamil—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00378	0.00491	CbGbCtD
Verapamil—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00367	0.00476	CbGbCtD
Verapamil—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00356	0.00462	CbGbCtD
Verapamil—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00352	0.00457	CbGbCtD
Verapamil—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00352	0.00457	CbGbCtD
Verapamil—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00342	0.00444	CbGbCtD
Verapamil—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00342	0.00444	CbGbCtD
Verapamil—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00337	0.00438	CbGbCtD
Verapamil—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00328	0.00425	CbGbCtD
Verapamil—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00322	0.00418	CbGbCtD
Verapamil—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00322	0.00418	CbGbCtD
Verapamil—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00318	0.00413	CbGbCtD
Verapamil—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00299	0.00388	CbGbCtD
Verapamil—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00299	0.00388	CbGbCtD
Verapamil—CACNA1A—nerve—acquired immunodeficiency syndrome	0.00295	0.0419	CbGeAlD
Verapamil—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0027	0.00351	CbGbCtD
Verapamil—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0027	0.00351	CbGbCtD
Verapamil—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00253	0.00329	CbGbCtD
Verapamil—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00233	0.00303	CbGbCtD
Verapamil—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00226	0.00294	CbGbCtD
Verapamil—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00205	0.00266	CbGbCtD
Verapamil—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00205	0.00266	CbGbCtD
Verapamil—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00196	0.00255	CbGbCtD
Verapamil—CACNA1F—retina—acquired immunodeficiency syndrome	0.00195	0.0276	CbGeAlD
Verapamil—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.000931	0.0132	CbGeAlD
Verapamil—ABCC3—blood plasma—acquired immunodeficiency syndrome	0.000883	0.0125	CbGeAlD
Verapamil—CACNB4—spinal cord—acquired immunodeficiency syndrome	0.000825	0.0117	CbGeAlD
Verapamil—CACNB4—vagina—acquired immunodeficiency syndrome	0.000794	0.0113	CbGeAlD
Verapamil—CACNA1B—spinal cord—acquired immunodeficiency syndrome	0.000769	0.0109	CbGeAlD
Verapamil—CACNB4—lung—acquired immunodeficiency syndrome	0.000751	0.0106	CbGeAlD
Verapamil—CACNA1G—digestive system—acquired immunodeficiency syndrome	0.000749	0.0106	CbGeAlD
Verapamil—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.000732	0.0104	CbGeAlD
Verapamil—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.000729	0.0103	CbGeAlD
Verapamil—CACNA1B—lung—acquired immunodeficiency syndrome	0.0007	0.00992	CbGeAlD
Verapamil—CACNB4—nervous system—acquired immunodeficiency syndrome	0.000695	0.00986	CbGeAlD
Verapamil—CACNB3—digestive system—acquired immunodeficiency syndrome	0.000689	0.00977	CbGeAlD
Verapamil—CACNB4—central nervous system—acquired immunodeficiency syndrome	0.00067	0.00949	CbGeAlD
Verapamil—CACNA1A—nervous system—acquired immunodeficiency syndrome	0.000664	0.00941	CbGeAlD
Verapamil—CACNB1—spinal cord—acquired immunodeficiency syndrome	0.000659	0.00935	CbGeAlD
Verapamil—CACNB2—retina—acquired immunodeficiency syndrome	0.000659	0.00934	CbGeAlD
Verapamil—CACNB3—blood—acquired immunodeficiency syndrome	0.000656	0.0093	CbGeAlD
Verapamil—CACNA1B—nervous system—acquired immunodeficiency syndrome	0.000648	0.00919	CbGeAlD
Verapamil—CACNA1I—brain—acquired immunodeficiency syndrome	0.000646	0.00916	CbGeAlD
Verapamil—CACNA1A—central nervous system—acquired immunodeficiency syndrome	0.000639	0.00906	CbGeAlD
Verapamil—CACNA1I—lymph node—acquired immunodeficiency syndrome	0.000624	0.00885	CbGeAlD
Verapamil—CACNA1B—central nervous system—acquired immunodeficiency syndrome	0.000624	0.00885	CbGeAlD
Verapamil—CACNB3—vagina—acquired immunodeficiency syndrome	0.000608	0.00862	CbGeAlD
Verapamil—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000606	0.0086	CbGeAlD
Verapamil—CACNA1G—nervous system—acquired immunodeficiency syndrome	0.000579	0.00821	CbGeAlD
Verapamil—CACNB3—lung—acquired immunodeficiency syndrome	0.000575	0.00816	CbGeAlD
Verapamil—CACNA1G—central nervous system—acquired immunodeficiency syndrome	0.000558	0.00791	CbGeAlD
Verapamil—CACNB1—nervous system—acquired immunodeficiency syndrome	0.000555	0.00787	CbGeAlD
Verapamil—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.000549	0.00778	CbGeAlD
Verapamil—CACNB1—central nervous system—acquired immunodeficiency syndrome	0.000535	0.00758	CbGeAlD
Verapamil—ABCB11—digestive system—acquired immunodeficiency syndrome	0.000534	0.00757	CbGeAlD
Verapamil—CACNB3—nervous system—acquired immunodeficiency syndrome	0.000533	0.00755	CbGeAlD
Verapamil—CACNB4—brain—acquired immunodeficiency syndrome	0.000532	0.00754	CbGeAlD
Verapamil—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000529	0.0075	CbGeAlD
Verapamil—CACNB3—central nervous system—acquired immunodeficiency syndrome	0.000513	0.00727	CbGeAlD
Verapamil—CACNA1A—brain—acquired immunodeficiency syndrome	0.000508	0.0072	CbGeAlD
Verapamil—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000495	0.00702	CbGeAlD
Verapamil—CACNA1B—brain—acquired immunodeficiency syndrome	0.000495	0.00702	CbGeAlD
Verapamil—CYP2C18—vagina—acquired immunodeficiency syndrome	0.000485	0.00687	CbGeAlD
Verapamil—CACNA1B—lymph node—acquired immunodeficiency syndrome	0.000479	0.00679	CbGeAlD
Verapamil—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000478	0.00677	CbGeAlD
Verapamil—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000475	0.00673	CbGeAlD
Verapamil—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00047	0.00667	CbGeAlD
Verapamil—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000465	0.048	CbGpPWpGaD
Verapamil—CACNB2—digestive system—acquired immunodeficiency syndrome	0.000463	0.00656	CbGeAlD
Verapamil—KCNJ11—lymphoid tissue—acquired immunodeficiency syndrome	0.000445	0.0063	CbGeAlD
Verapamil—CACNA1G—brain—acquired immunodeficiency syndrome	0.000443	0.00628	CbGeAlD
Verapamil—CACNB1—brain—acquired immunodeficiency syndrome	0.000425	0.00602	CbGeAlD
Verapamil—CACNB1—lymph node—acquired immunodeficiency syndrome	0.00041	0.00582	CbGeAlD
Verapamil—CACNB2—vagina—acquired immunodeficiency syndrome	0.000409	0.00579	CbGeAlD
Verapamil—CACNB3—brain—acquired immunodeficiency syndrome	0.000407	0.00577	CbGeAlD
Verapamil—CACNB3—lymph node—acquired immunodeficiency syndrome	0.000393	0.00558	CbGeAlD
Verapamil—CACNB4—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000389	0.04	CbGpPWpGaD
Verapamil—CACNB2—lung—acquired immunodeficiency syndrome	0.000386	0.00548	CbGeAlD
Verapamil—CACNA1H—nervous system—acquired immunodeficiency syndrome	0.000379	0.00537	CbGeAlD
Verapamil—CACNA1C—digestive system—acquired immunodeficiency syndrome	0.000373	0.00529	CbGeAlD
Verapamil—SCN5A—digestive system—acquired immunodeficiency syndrome	0.000362	0.00513	CbGeAlD
Verapamil—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000359	0.00508	CbGeAlD
Verapamil—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000358	0.00508	CbGeAlD
Verapamil—CACNB2—nervous system—acquired immunodeficiency syndrome	0.000358	0.00507	CbGeAlD
Verapamil—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000353	0.005	CbGeAlD
Verapamil—SCN5A—blood—acquired immunodeficiency syndrome	0.000345	0.00489	CbGeAlD
Verapamil—CACNB2—central nervous system—acquired immunodeficiency syndrome	0.000345	0.00489	CbGeAlD
Verapamil—ABCC10—lymphoid tissue—acquired immunodeficiency syndrome	0.000342	0.00485	CbGeAlD
Verapamil—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000341	0.00484	CbGeAlD
Verapamil—ABCC3—digestive system—acquired immunodeficiency syndrome	0.00034	0.00482	CbGeAlD
Verapamil—KCNJ11—nervous system—acquired immunodeficiency syndrome	0.00034	0.00482	CbGeAlD
Verapamil—ABCC10—digestive system—acquired immunodeficiency syndrome	0.000338	0.00479	CbGeAlD
Verapamil—CACNA1D—lung—acquired immunodeficiency syndrome	0.000338	0.00479	CbGeAlD
Verapamil—CACNA1C—vagina—acquired immunodeficiency syndrome	0.00033	0.00467	CbGeAlD
Verapamil—KCNJ11—central nervous system—acquired immunodeficiency syndrome	0.000327	0.00464	CbGeAlD
Verapamil—ABCC3—blood—acquired immunodeficiency syndrome	0.000324	0.00459	CbGeAlD
Verapamil—ABCC10—blood—acquired immunodeficiency syndrome	0.000322	0.00457	CbGeAlD
Verapamil—SCN5A—vagina—acquired immunodeficiency syndrome	0.00032	0.00453	CbGeAlD
Verapamil—SLC22A4—digestive system—acquired immunodeficiency syndrome	0.000318	0.0045	CbGeAlD
Verapamil—CACNA1D—nervous system—acquired immunodeficiency syndrome	0.000313	0.00444	CbGeAlD
Verapamil—CACNA1C—lung—acquired immunodeficiency syndrome	0.000312	0.00442	CbGeAlD
Verapamil—ABCC10—bone marrow—acquired immunodeficiency syndrome	0.000312	0.00442	CbGeAlD
Verapamil—CACNB3—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000311	0.032	CbGpPWpGaD
Verapamil—ABCC10—spinal cord—acquired immunodeficiency syndrome	0.00031	0.0044	CbGeAlD
Verapamil—SLC22A4—blood—acquired immunodeficiency syndrome	0.000303	0.00429	CbGeAlD
Verapamil—CACNB1—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000302	0.0311	CbGpPWpGaD
Verapamil—CACNA1D—central nervous system—acquired immunodeficiency syndrome	0.000301	0.00427	CbGeAlD
Verapamil—SLC22A5—retina—acquired immunodeficiency syndrome	0.000299	0.00425	CbGeAlD
Verapamil—ABCC10—vagina—acquired immunodeficiency syndrome	0.000298	0.00423	CbGeAlD
Verapamil—SLC22A4—bone marrow—acquired immunodeficiency syndrome	0.000293	0.00415	CbGeAlD
Verapamil—SLC22A4—spinal cord—acquired immunodeficiency syndrome	0.000292	0.00413	CbGeAlD
Verapamil—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000291	0.00413	CbGeAlD
Verapamil—CACNA1H—brain—acquired immunodeficiency syndrome	0.00029	0.00411	CbGeAlD
Verapamil—CACNA1C—nervous system—acquired immunodeficiency syndrome	0.000289	0.00409	CbGeAlD
Verapamil—SLC22A1—blood—acquired immunodeficiency syndrome	0.000288	0.00409	CbGeAlD
Verapamil—ABCC3—lung—acquired immunodeficiency syndrome	0.000284	0.00402	CbGeAlD
Verapamil—ABCC10—lung—acquired immunodeficiency syndrome	0.000282	0.004	CbGeAlD
Verapamil—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000281	0.00399	CbGeAlD
Verapamil—SLC22A4—vagina—acquired immunodeficiency syndrome	0.000281	0.00398	CbGeAlD
Verapamil—ABCC4—digestive system—acquired immunodeficiency syndrome	0.00028	0.00398	CbGeAlD
Verapamil—CACNA1H—lymph node—acquired immunodeficiency syndrome	0.00028	0.00397	CbGeAlD
Verapamil—SCN5A—nervous system—acquired immunodeficiency syndrome	0.00028	0.00397	CbGeAlD
Verapamil—CACNA1C—central nervous system—acquired immunodeficiency syndrome	0.000278	0.00394	CbGeAlD
Verapamil—CACNB2—brain—acquired immunodeficiency syndrome	0.000274	0.00388	CbGeAlD
Verapamil—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000271	0.00385	CbGeAlD
Verapamil—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.000269	0.00382	CbGeAlD
Verapamil—SLC6A4—blood—acquired immunodeficiency syndrome	0.000268	0.0038	CbGeAlD
Verapamil—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000267	0.00379	CbGeAlD
Verapamil—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000267	0.00379	CbGeAlD
Verapamil—ABCC4—blood—acquired immunodeficiency syndrome	0.000267	0.00379	CbGeAlD
Verapamil—SLC22A4—lung—acquired immunodeficiency syndrome	0.000265	0.00376	CbGeAlD
Verapamil—CACNB2—lymph node—acquired immunodeficiency syndrome	0.000264	0.00375	CbGeAlD
Verapamil—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000263	0.00373	CbGeAlD
Verapamil—ABCC3—nervous system—acquired immunodeficiency syndrome	0.000263	0.00372	CbGeAlD
Verapamil—KCNJ11—brain—acquired immunodeficiency syndrome	0.00026	0.00368	CbGeAlD
Verapamil—ABCC2—blood—acquired immunodeficiency syndrome	0.000259	0.00367	CbGeAlD
Verapamil—ABCC4—bone marrow—acquired immunodeficiency syndrome	0.000258	0.00366	CbGeAlD
Verapamil—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000258	0.00366	CbGeAlD
Verapamil—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000254	0.0036	CbGeAlD
Verapamil—ABCC3—central nervous system—acquired immunodeficiency syndrome	0.000253	0.00359	CbGeAlD
Verapamil—KCNJ11—lymph node—acquired immunodeficiency syndrome	0.000251	0.00356	CbGeAlD
Verapamil—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000243	0.00345	CbGeAlD
Verapamil—CACNA1D—brain—acquired immunodeficiency syndrome	0.000239	0.00339	CbGeAlD
Verapamil—SLC6A4—lung—acquired immunodeficiency syndrome	0.000235	0.00333	CbGeAlD
Verapamil—ABCC4—lung—acquired immunodeficiency syndrome	0.000234	0.00332	CbGeAlD
Verapamil—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000234	0.00332	CbGeAlD
Verapamil—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000233	0.00331	CbGeAlD
Verapamil—CACNA1D—lymph node—acquired immunodeficiency syndrome	0.000231	0.00328	CbGeAlD
Verapamil—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000228	0.00324	CbGeAlD
Verapamil—ABCC1—blood—acquired immunodeficiency syndrome	0.000228	0.00323	CbGeAlD
Verapamil—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000225	0.00319	CbGeAlD
Verapamil—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000225	0.00319	CbGeAlD
Verapamil—CYP2C19—blood—acquired immunodeficiency syndrome	0.000222	0.00315	CbGeAlD
Verapamil—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000221	0.0228	CbGpPWpGaD
Verapamil—CACNA1C—brain—acquired immunodeficiency syndrome	0.000221	0.00313	CbGeAlD
Verapamil—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000218	0.00309	CbGeAlD
Verapamil—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000217	0.00308	CbGeAlD
Verapamil—ABCC4—nervous system—acquired immunodeficiency syndrome	0.000217	0.00307	CbGeAlD
Verapamil—SCN5A—brain—acquired immunodeficiency syndrome	0.000214	0.00303	CbGeAlD
Verapamil—CACNA1C—lymph node—acquired immunodeficiency syndrome	0.000213	0.00302	CbGeAlD
Verapamil—KCNH2—blood—acquired immunodeficiency syndrome	0.000212	0.003	CbGeAlD
Verapamil—ABCC1—vagina—acquired immunodeficiency syndrome	0.000211	0.00299	CbGeAlD
Verapamil—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.00021	0.00298	CbGeAlD
Verapamil—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.00021	0.00297	CbGeAlD
Verapamil—ABCC4—central nervous system—acquired immunodeficiency syndrome	0.000209	0.00296	CbGeAlD
Verapamil—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000206	0.00292	CbGeAlD
Verapamil—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.000205	0.00291	CbGeAlD
Verapamil—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000204	0.0029	CbGeAlD
Verapamil—ABCC3—brain—acquired immunodeficiency syndrome	0.000201	0.00285	CbGeAlD
Verapamil—SLC22A5—blood—acquired immunodeficiency syndrome	0.0002	0.00284	CbGeAlD
Verapamil—ABCC10—brain—acquired immunodeficiency syndrome	0.0002	0.00283	CbGeAlD
Verapamil—ABCC1—lung—acquired immunodeficiency syndrome	0.0002	0.00283	CbGeAlD
Verapamil—KCNH2—vagina—acquired immunodeficiency syndrome	0.000196	0.00279	CbGeAlD
Verapamil—ABCC3—lymph node—acquired immunodeficiency syndrome	0.000194	0.00275	CbGeAlD
Verapamil—CYP2C8—blood—acquired immunodeficiency syndrome	0.000194	0.00275	CbGeAlD
Verapamil—ABCC10—lymph node—acquired immunodeficiency syndrome	0.000193	0.00274	CbGeAlD
Verapamil—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000193	0.00274	CbGeAlD
Verapamil—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00019	0.0027	CbGeAlD
Verapamil—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.00019	0.0195	CbGpPWpGaD
Verapamil—ABCG2—blood—acquired immunodeficiency syndrome	0.000189	0.00267	CbGeAlD
Verapamil—SLC22A4—brain—acquired immunodeficiency syndrome	0.000188	0.00266	CbGeAlD
Verapamil—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000186	0.00263	CbGeAlD
Verapamil—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000185	0.00262	CbGeAlD
Verapamil—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000184	0.0026	CbGeAlD
Verapamil—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000183	0.00259	CbGeAlD
Verapamil—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000182	0.00259	CbGeAlD
Verapamil—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000182	0.00258	CbGeAlD
Verapamil—SLC22A4—lymph node—acquired immunodeficiency syndrome	0.000181	0.00257	CbGeAlD
Verapamil—CYP1A2—blood—acquired immunodeficiency syndrome	0.000181	0.00257	CbGeAlD
Verapamil—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000181	0.00256	CbGeAlD
Verapamil—CYP2C8—vagina—acquired immunodeficiency syndrome	0.00018	0.00255	CbGeAlD
Verapamil—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.00018	0.0185	CbGpPWpGaD
Verapamil—SLC22A1—brain—acquired immunodeficiency syndrome	0.000179	0.00254	CbGeAlD
Verapamil—SLC22A5—lung—acquired immunodeficiency syndrome	0.000176	0.00249	CbGeAlD
Verapamil—CYP3A5—blood—acquired immunodeficiency syndrome	0.000175	0.00248	CbGeAlD
Verapamil—ABCG2—vagina—acquired immunodeficiency syndrome	0.000175	0.00248	CbGeAlD
Verapamil—CYP2B6—blood—acquired immunodeficiency syndrome	0.000174	0.00247	CbGeAlD
Verapamil—CYP2C9—blood—acquired immunodeficiency syndrome	0.000172	0.00244	CbGeAlD
Verapamil—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000172	0.00244	CbGeAlD
Verapamil—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000172	0.00244	CbGeAlD
Verapamil—CACNB3—Myometrial Relaxation and Contraction Pathways—ACTG1—acquired immunodeficiency syndrome	0.000172	0.0177	CbGpPWpGaD
Verapamil—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.00113	CcSEcCtD
Verapamil—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.00112	CcSEcCtD
Verapamil—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000168	0.00112	CcSEcCtD
Verapamil—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.00112	CcSEcCtD
Verapamil—SLCO1A2—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000167	0.0173	CbGpPWpGaD
Verapamil—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.00112	CcSEcCtD
Verapamil—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.00111	CcSEcCtD
Verapamil—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.00111	CcSEcCtD
Verapamil—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.00111	CcSEcCtD
Verapamil—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00111	CcSEcCtD
Verapamil—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00111	CcSEcCtD
Verapamil—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000167	0.00111	CcSEcCtD
Verapamil—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.00111	CcSEcCtD
Verapamil—SLC6A4—brain—acquired immunodeficiency syndrome	0.000166	0.00236	CbGeAlD
Verapamil—ABCC4—brain—acquired immunodeficiency syndrome	0.000166	0.00235	CbGeAlD
Verapamil—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000166	0.00235	CbGeAlD
Verapamil—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000166	0.0011	CcSEcCtD
Verapamil—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.0011	CcSEcCtD
Verapamil—ABCG2—lung—acquired immunodeficiency syndrome	0.000165	0.00234	CbGeAlD
Verapamil—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.0011	CcSEcCtD
Verapamil—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000165	0.0011	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000165	0.0011	CcSEcCtD
Verapamil—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000164	0.0011	CcSEcCtD
Verapamil—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000164	0.0011	CcSEcCtD
Verapamil—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.00109	CcSEcCtD
Verapamil—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.00109	CcSEcCtD
Verapamil—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000164	0.00109	CcSEcCtD
Verapamil—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00109	CcSEcCtD
Verapamil—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.00109	CcSEcCtD
Verapamil—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.00109	CcSEcCtD
Verapamil—Rash—Didanosine—acquired immunodeficiency syndrome	0.000163	0.00109	CcSEcCtD
Verapamil—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00109	CcSEcCtD
Verapamil—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000163	0.00109	CcSEcCtD
Verapamil—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000163	0.00109	CcSEcCtD
Verapamil—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000163	0.00108	CcSEcCtD
Verapamil—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000162	0.0023	CbGeAlD
Verapamil—Headache—Didanosine—acquired immunodeficiency syndrome	0.000162	0.00108	CcSEcCtD
Verapamil—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000162	0.00108	CcSEcCtD
Verapamil—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000161	0.00108	CcSEcCtD
Verapamil—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000161	0.00229	CbGeAlD
Verapamil—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.00107	CcSEcCtD
Verapamil—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000161	0.00107	CcSEcCtD
Verapamil—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000161	0.00107	CcSEcCtD
Verapamil—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.00107	CcSEcCtD
Verapamil—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.00107	CcSEcCtD
Verapamil—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.00107	CcSEcCtD
Verapamil—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.00107	CcSEcCtD
Verapamil—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.00107	CcSEcCtD
Verapamil—ABCC4—lymph node—acquired immunodeficiency syndrome	0.00016	0.00227	CbGeAlD
Verapamil—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.00107	CcSEcCtD
Verapamil—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.00106	CcSEcCtD
Verapamil—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000159	0.00106	CcSEcCtD
Verapamil—CYP1A2—lung—acquired immunodeficiency syndrome	0.000159	0.00226	CbGeAlD
Verapamil—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000159	0.00106	CcSEcCtD
Verapamil—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000159	0.00106	CcSEcCtD
Verapamil—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000159	0.00106	CcSEcCtD
Verapamil—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000158	0.00106	CcSEcCtD
Verapamil—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00106	CcSEcCtD
Verapamil—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00105	CcSEcCtD
Verapamil—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00105	CcSEcCtD
Verapamil—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00105	CcSEcCtD
Verapamil—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000158	0.0163	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000157	0.0162	CbGpPWpGaD
Verapamil—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00105	CcSEcCtD
Verapamil—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000156	0.00104	CcSEcCtD
Verapamil—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000156	0.00104	CcSEcCtD
Verapamil—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.00104	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.00104	CcSEcCtD
Verapamil—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.00104	CcSEcCtD
Verapamil—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000155	0.0022	CbGeAlD
Verapamil—Pain—Indinavir—acquired immunodeficiency syndrome	0.000155	0.00103	CcSEcCtD
Verapamil—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000155	0.00103	CcSEcCtD
Verapamil—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000155	0.00103	CcSEcCtD
Verapamil—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000155	0.00103	CcSEcCtD
Verapamil—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.00103	CcSEcCtD
Verapamil—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00103	CcSEcCtD
Verapamil—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.00103	CcSEcCtD
Verapamil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000154	0.00103	CcSEcCtD
Verapamil—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.00103	CcSEcCtD
Verapamil—CYP3A5—lung—acquired immunodeficiency syndrome	0.000153	0.00218	CbGeAlD
Verapamil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000153	0.00102	CcSEcCtD
Verapamil—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000153	0.00102	CcSEcCtD
Verapamil—KCNH2—Hematopoietic Stem Cell Differentiation—CXCR4—acquired immunodeficiency syndrome	0.000153	0.0158	CbGpPWpGaD
Verapamil—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.00102	CcSEcCtD
Verapamil—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.00102	CcSEcCtD
Verapamil—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.00102	CcSEcCtD
Verapamil—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.00102	CcSEcCtD
Verapamil—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.00102	CcSEcCtD
Verapamil—CYP2B6—lung—acquired immunodeficiency syndrome	0.000152	0.00216	CbGeAlD
Verapamil—CACNA1A—Type II diabetes mellitus—TNF—acquired immunodeficiency syndrome	0.000152	0.0157	CbGpPWpGaD
Verapamil—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.00102	CcSEcCtD
Verapamil—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00101	CcSEcCtD
Verapamil—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00101	CcSEcCtD
Verapamil—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00101	CcSEcCtD
Verapamil—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.00101	CcSEcCtD
Verapamil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000151	0.00101	CcSEcCtD
Verapamil—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.00101	CcSEcCtD
Verapamil—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.001	CcSEcCtD
Verapamil—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000999	CcSEcCtD
Verapamil—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000996	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000995	CcSEcCtD
Verapamil—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000994	CcSEcCtD
Verapamil—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000992	CcSEcCtD
Verapamil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000149	0.000992	CcSEcCtD
Verapamil—ABCB11—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000149	0.0153	CbGpPWpGaD
Verapamil—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000148	0.000989	CcSEcCtD
Verapamil—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000988	CcSEcCtD
Verapamil—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000986	CcSEcCtD
Verapamil—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000985	CcSEcCtD
Verapamil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000148	0.000985	CcSEcCtD
Verapamil—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000985	CcSEcCtD
Verapamil—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000981	CcSEcCtD
Verapamil—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000981	CcSEcCtD
Verapamil—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000977	CcSEcCtD
Verapamil—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000977	CcSEcCtD
Verapamil—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000977	CcSEcCtD
Verapamil—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000146	0.000976	CcSEcCtD
Verapamil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000146	0.000976	CcSEcCtD
Verapamil—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000974	CcSEcCtD
Verapamil—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000146	0.000974	CcSEcCtD
Verapamil—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000972	CcSEcCtD
Verapamil—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000971	CcSEcCtD
Verapamil—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000145	0.00097	CcSEcCtD
Verapamil—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000968	CcSEcCtD
Verapamil—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000968	CcSEcCtD
Verapamil—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000968	CcSEcCtD
Verapamil—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000966	CcSEcCtD
Verapamil—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000962	CcSEcCtD
Verapamil—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000144	0.00096	CcSEcCtD
Verapamil—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000957	CcSEcCtD
Verapamil—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000956	CcSEcCtD
Verapamil—SLCO1B1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000143	0.0148	CbGpPWpGaD
Verapamil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000143	0.000954	CcSEcCtD
Verapamil—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000143	0.000951	CcSEcCtD
Verapamil—ABCC3—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000143	0.0147	CbGpPWpGaD
Verapamil—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000946	CcSEcCtD
Verapamil—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000142	0.000946	CcSEcCtD
Verapamil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000142	0.000945	CcSEcCtD
Verapamil—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000944	CcSEcCtD
Verapamil—Rash—Stavudine—acquired immunodeficiency syndrome	0.000141	0.000943	CcSEcCtD
Verapamil—ABCC1—brain—acquired immunodeficiency syndrome	0.000141	0.002	CbGeAlD
Verapamil—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000141	0.002	CbGeAlD
Verapamil—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000942	CcSEcCtD
Verapamil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000141	0.000942	CcSEcCtD
Verapamil—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000941	CcSEcCtD
Verapamil—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00094	CcSEcCtD
Verapamil—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000141	0.00094	CcSEcCtD
Verapamil—Headache—Stavudine—acquired immunodeficiency syndrome	0.00014	0.000937	CcSEcCtD
Verapamil—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00014	0.000937	CcSEcCtD
Verapamil—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000935	CcSEcCtD
Verapamil—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000934	CcSEcCtD
Verapamil—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000934	CcSEcCtD
Verapamil—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00014	0.000932	CcSEcCtD
Verapamil—Rash—Abacavir—acquired immunodeficiency syndrome	0.000139	0.000929	CcSEcCtD
Verapamil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000139	0.000928	CcSEcCtD
Verapamil—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000928	CcSEcCtD
Verapamil—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000928	CcSEcCtD
Verapamil—ABCB1—retina—acquired immunodeficiency syndrome	0.000139	0.00197	CbGeAlD
Verapamil—Headache—Abacavir—acquired immunodeficiency syndrome	0.000138	0.000923	CcSEcCtD
Verapamil—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000922	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000921	CcSEcCtD
Verapamil—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000138	0.00092	CcSEcCtD
Verapamil—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000138	0.00195	CbGeAlD
Verapamil—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000919	CcSEcCtD
Verapamil—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000914	CcSEcCtD
Verapamil—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000913	CcSEcCtD
Verapamil—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000137	0.00194	CbGeAlD
Verapamil—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000909	CcSEcCtD
Verapamil—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000907	CcSEcCtD
Verapamil—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000907	CcSEcCtD
Verapamil—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000136	0.00193	CbGeAlD
Verapamil—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000136	0.00192	CbGeAlD
Verapamil—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000901	CcSEcCtD
Verapamil—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.0009	CcSEcCtD
Verapamil—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000898	CcSEcCtD
Verapamil—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000897	CcSEcCtD
Verapamil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000134	0.000891	CcSEcCtD
Verapamil—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000133	0.00089	CcSEcCtD
Verapamil—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000889	CcSEcCtD
Verapamil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000889	CcSEcCtD
Verapamil—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000133	0.000888	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000886	CcSEcCtD
Verapamil—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.00088	CcSEcCtD
Verapamil—KCNH2—brain—acquired immunodeficiency syndrome	0.000132	0.00186	CbGeAlD
Verapamil—CYP3A4—blood—acquired immunodeficiency syndrome	0.000131	0.00186	CbGeAlD
Verapamil—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000131	0.000875	CcSEcCtD
Verapamil—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000873	CcSEcCtD
Verapamil—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000871	CcSEcCtD
Verapamil—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000868	CcSEcCtD
Verapamil—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00013	0.000867	CcSEcCtD
Verapamil—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000867	CcSEcCtD
Verapamil—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000867	CcSEcCtD
Verapamil—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000865	CcSEcCtD
Verapamil—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000864	CcSEcCtD
Verapamil—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000864	CcSEcCtD
Verapamil—CYP2D6—blood—acquired immunodeficiency syndrome	0.000129	0.00183	CbGeAlD
Verapamil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000859	CcSEcCtD
Verapamil—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000856	CcSEcCtD
Verapamil—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000855	CcSEcCtD
Verapamil—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000127	0.0018	CbGeAlD
Verapamil—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000845	CcSEcCtD
Verapamil—SCN5A—Cardiac Progenitor Differentiation—CXCR4—acquired immunodeficiency syndrome	0.000126	0.013	CbGpPWpGaD
Verapamil—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000841	CcSEcCtD
Verapamil—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000839	CcSEcCtD
Verapamil—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000838	CcSEcCtD
Verapamil—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000833	CcSEcCtD
Verapamil—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000833	CcSEcCtD
Verapamil—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000832	CcSEcCtD
Verapamil—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000832	CcSEcCtD
Verapamil—SLC22A5—brain—acquired immunodeficiency syndrome	0.000124	0.00176	CbGeAlD
Verapamil—SLCO1A2—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000124	0.0128	CbGpPWpGaD
Verapamil—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000827	CcSEcCtD
Verapamil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000827	CcSEcCtD
Verapamil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.000826	CcSEcCtD
Verapamil—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000825	CcSEcCtD
Verapamil—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000123	0.000819	CcSEcCtD
Verapamil—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000819	CcSEcCtD
Verapamil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000123	0.000819	CcSEcCtD
Verapamil—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000817	CcSEcCtD
Verapamil—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000122	0.000814	CcSEcCtD
Verapamil—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000808	CcSEcCtD
Verapamil—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000805	CcSEcCtD
Verapamil—CYP2C8—brain—acquired immunodeficiency syndrome	0.00012	0.00171	CbGeAlD
Verapamil—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000803	CcSEcCtD
Verapamil—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000801	CcSEcCtD
Verapamil—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.00012	0.0017	CbGeAlD
Verapamil—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.0008	CcSEcCtD
Verapamil—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000799	CcSEcCtD
Verapamil—CACNB4—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000119	0.0123	CbGpPWpGaD
Verapamil—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000793	CcSEcCtD
Verapamil—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000793	CcSEcCtD
Verapamil—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000784	CcSEcCtD
Verapamil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000781	CcSEcCtD
Verapamil—ABCG2—brain—acquired immunodeficiency syndrome	0.000117	0.00166	CbGeAlD
Verapamil—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000773	CcSEcCtD
Verapamil—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000773	CcSEcCtD
Verapamil—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000772	CcSEcCtD
Verapamil—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000768	CcSEcCtD
Verapamil—KCNH2—Hematopoietic Stem Cell Differentiation—CSF2—acquired immunodeficiency syndrome	0.000115	0.0118	CbGpPWpGaD
Verapamil—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000764	CcSEcCtD
Verapamil—Rash—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000762	CcSEcCtD
Verapamil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000761	CcSEcCtD
Verapamil—Headache—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000757	CcSEcCtD
Verapamil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000755	CcSEcCtD
Verapamil—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000113	0.0016	CbGeAlD
Verapamil—CACNA1I—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000112	0.0115	CbGpPWpGaD
Verapamil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000748	CcSEcCtD
Verapamil—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000744	CcSEcCtD
Verapamil—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000737	CcSEcCtD
Verapamil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000726	CcSEcCtD
Verapamil—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000725	CcSEcCtD
Verapamil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000722	CcSEcCtD
Verapamil—CYP2B6—brain—acquired immunodeficiency syndrome	0.000108	0.00153	CbGeAlD
Verapamil—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.00072	CcSEcCtD
Verapamil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000719	CcSEcCtD
Verapamil—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000718	CcSEcCtD
Verapamil—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000716	CcSEcCtD
Verapamil—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000715	CcSEcCtD
Verapamil—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000715	CcSEcCtD
Verapamil—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000107	0.00151	CbGeAlD
Verapamil—SLCO1B1—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000106	0.0109	CbGpPWpGaD
Verapamil—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000105	0.00149	CbGeAlD
Verapamil—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000698	CcSEcCtD
Verapamil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000695	CcSEcCtD
Verapamil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000691	CcSEcCtD
Verapamil—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000689	CcSEcCtD
Verapamil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000688	CcSEcCtD
Verapamil—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000688	CcSEcCtD
Verapamil—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000103	0.00146	CbGeAlD
Verapamil—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000684	CcSEcCtD
Verapamil—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000684	CcSEcCtD
Verapamil—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000678	CcSEcCtD
Verapamil—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000101	0.00143	CbGeAlD
Verapamil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000668	CcSEcCtD
Verapamil—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.98e-05	0.000666	CcSEcCtD
Verapamil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.97e-05	0.000665	CcSEcCtD
Verapamil—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	9.88e-05	0.0014	CbGeAlD
Verapamil—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.84e-05	0.000656	CcSEcCtD
Verapamil—ABCB1—digestive system—acquired immunodeficiency syndrome	9.76e-05	0.00138	CbGeAlD
Verapamil—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.73e-05	0.000649	CcSEcCtD
Verapamil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.64e-05	0.000643	CcSEcCtD
Verapamil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.63e-05	0.000642	CcSEcCtD
Verapamil—Rash—Ritonavir—acquired immunodeficiency syndrome	9.55e-05	0.000637	CcSEcCtD
Verapamil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.54e-05	0.000636	CcSEcCtD
Verapamil—CACNB3—Axon guidance—ACTG1—acquired immunodeficiency syndrome	9.53e-05	0.00982	CbGpPWpGaD
Verapamil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.52e-05	0.000635	CcSEcCtD
Verapamil—Headache—Ritonavir—acquired immunodeficiency syndrome	9.49e-05	0.000633	CcSEcCtD
Verapamil—ABCB1—blood—acquired immunodeficiency syndrome	9.3e-05	0.00132	CbGeAlD
Verapamil—CACNB1—Axon guidance—ACTG1—acquired immunodeficiency syndrome	9.27e-05	0.00955	CbGpPWpGaD
Verapamil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	9.27e-05	0.000618	CcSEcCtD
Verapamil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	9.2e-05	0.000613	CcSEcCtD
Verapamil—Rash—Saquinavir—acquired immunodeficiency syndrome	9.19e-05	0.000613	CcSEcCtD
Verapamil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	9.18e-05	0.000613	CcSEcCtD
Verapamil—CACNA1F—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	9.15e-05	0.00942	CbGpPWpGaD
Verapamil—Headache—Saquinavir—acquired immunodeficiency syndrome	9.13e-05	0.000609	CcSEcCtD
Verapamil—Nausea—Ritonavir—acquired immunodeficiency syndrome	9e-05	0.0006	CcSEcCtD
Verapamil—ABCB1—bone marrow—acquired immunodeficiency syndrome	9e-05	0.00128	CbGeAlD
Verapamil—ABCB1—spinal cord—acquired immunodeficiency syndrome	8.96e-05	0.00127	CbGeAlD
Verapamil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.84e-05	0.00059	CcSEcCtD
Verapamil—Rash—Lamivudine—acquired immunodeficiency syndrome	8.77e-05	0.000585	CcSEcCtD
Verapamil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.76e-05	0.000584	CcSEcCtD
Verapamil—Headache—Lamivudine—acquired immunodeficiency syndrome	8.71e-05	0.000581	CcSEcCtD
Verapamil—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.66e-05	0.000578	CcSEcCtD
Verapamil—ABCB1—vagina—acquired immunodeficiency syndrome	8.62e-05	0.00122	CbGeAlD
Verapamil—CACNB4—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	8.51e-05	0.00877	CbGpPWpGaD
Verapamil—KCNJ11—Type II diabetes mellitus—TNF—acquired immunodeficiency syndrome	8.35e-05	0.0086	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—ACTG1—acquired immunodeficiency syndrome	8.26e-05	0.00851	CbGpPWpGaD
Verapamil—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.26e-05	0.000551	CcSEcCtD
Verapamil—ABCB1—lung—acquired immunodeficiency syndrome	8.15e-05	0.00116	CbGeAlD
Verapamil—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	8.12e-05	0.00836	CbGpPWpGaD
Verapamil—CYP2D6—brain—acquired immunodeficiency syndrome	8.02e-05	0.00114	CbGeAlD
Verapamil—CACNA1H—Axon guidance—ACTG1—acquired immunodeficiency syndrome	8e-05	0.00825	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	8e-05	0.00824	CbGpPWpGaD
Verapamil—ABCB11—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	7.77e-05	0.00801	CbGpPWpGaD
Verapamil—ABCB1—nervous system—acquired immunodeficiency syndrome	7.55e-05	0.00107	CbGeAlD
Verapamil—ABCC3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	7.45e-05	0.00768	CbGpPWpGaD
Verapamil—ABCB1—central nervous system—acquired immunodeficiency syndrome	7.27e-05	0.00103	CbGeAlD
Verapamil—CACNB3—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	6.8e-05	0.00701	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—ACTG1—acquired immunodeficiency syndrome	6.79e-05	0.007	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	6.62e-05	0.00682	CbGpPWpGaD
Verapamil—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	6.49e-05	0.00668	CbGpPWpGaD
Verapamil—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	6.48e-05	0.00667	CbGpPWpGaD
Verapamil—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	6.48e-05	0.00667	CbGpPWpGaD
Verapamil—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	6.21e-05	0.0064	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	5.9e-05	0.00608	CbGpPWpGaD
Verapamil—CACNB4—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	5.86e-05	0.00604	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—ACTG1—acquired immunodeficiency syndrome	5.82e-05	0.006	CbGpPWpGaD
Verapamil—ABCB1—brain—acquired immunodeficiency syndrome	5.77e-05	0.000818	CbGeAlD
Verapamil—CACNA1H—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	5.71e-05	0.00588	CbGpPWpGaD
Verapamil—ABCB1—lymph node—acquired immunodeficiency syndrome	5.57e-05	0.00079	CbGeAlD
Verapamil—SLCO1B1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	5.55e-05	0.00572	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—ACTG1—acquired immunodeficiency syndrome	5.51e-05	0.00568	CbGpPWpGaD
Verapamil—CACNA1I—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	5.51e-05	0.00568	CbGpPWpGaD
Verapamil—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	5.31e-05	0.00547	CbGpPWpGaD
Verapamil—CACNA1H—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	5.26e-05	0.00542	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—ACTG1—acquired immunodeficiency syndrome	4.9e-05	0.00505	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—TAT—acquired immunodeficiency syndrome	4.88e-05	0.00503	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	4.85e-05	0.00499	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—ACTG1—acquired immunodeficiency syndrome	4.84e-05	0.00499	CbGpPWpGaD
Verapamil—SLC6A4—Monoamine Transport—TNF—acquired immunodeficiency syndrome	4.76e-05	0.0049	CbGpPWpGaD
Verapamil—CACNB3—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	4.69e-05	0.00483	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—TAT—acquired immunodeficiency syndrome	4.59e-05	0.00473	CbGpPWpGaD
Verapamil—CACNB1—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	4.56e-05	0.0047	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.16e-05	0.00429	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	4.15e-05	0.00428	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—AGPS—acquired immunodeficiency syndrome	4.15e-05	0.00428	CbGpPWpGaD
Verapamil—CACNA1G—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	4.06e-05	0.00419	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	4.03e-05	0.00416	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.99e-05	0.00411	CbGpPWpGaD
Verapamil—CACNA1H—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	3.94e-05	0.00405	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	3.93e-05	0.00405	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	3.91e-05	0.00403	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—AGPS—acquired immunodeficiency syndrome	3.9e-05	0.00402	CbGpPWpGaD
Verapamil—ABCC4—Platelet degranulation—ALB—acquired immunodeficiency syndrome	3.7e-05	0.00381	CbGpPWpGaD
Verapamil—CACNA1S—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	3.67e-05	0.00378	CbGpPWpGaD
Verapamil—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—acquired immunodeficiency syndrome	3.57e-05	0.00368	CbGpPWpGaD
Verapamil—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	3.52e-05	0.00363	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	3.52e-05	0.00363	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	3.5e-05	0.00361	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	3.5e-05	0.00361	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	3.49e-05	0.0036	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.48e-05	0.00358	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	3.46e-05	0.00356	CbGpPWpGaD
Verapamil—CACNA1S—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	3.34e-05	0.00344	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.13e-05	0.00322	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	3.03e-05	0.00312	CbGpPWpGaD
Verapamil—CACNA1D—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	2.98e-05	0.00307	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.97e-05	0.00306	CbGpPWpGaD
Verapamil—CACNB2—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	2.86e-05	0.00295	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—TAT—acquired immunodeficiency syndrome	2.8e-05	0.00289	CbGpPWpGaD
Verapamil—CACNA1D—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	2.71e-05	0.00279	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—TAT—acquired immunodeficiency syndrome	2.67e-05	0.00276	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—TAT—acquired immunodeficiency syndrome	2.66e-05	0.00274	CbGpPWpGaD
Verapamil—CACNA1C—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	2.62e-05	0.0027	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	2.52e-05	0.00259	CbGpPWpGaD
Verapamil—CACNB3—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	2.42e-05	0.0025	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.38e-05	0.00246	CbGpPWpGaD
Verapamil—CACNA1C—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	2.38e-05	0.00245	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—TAT—acquired immunodeficiency syndrome	2.33e-05	0.0024	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	2.3e-05	0.00237	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	2.3e-05	0.00237	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AGPS—acquired immunodeficiency syndrome	2.27e-05	0.00234	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AGPS—acquired immunodeficiency syndrome	2.26e-05	0.00233	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	2.24e-05	0.0023	CbGpPWpGaD
Verapamil—SLC22A4—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.21e-05	0.00228	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	2.19e-05	0.00225	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—TAT—acquired immunodeficiency syndrome	2.18e-05	0.00225	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—TAT—acquired immunodeficiency syndrome	2.15e-05	0.00221	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—TAT—acquired immunodeficiency syndrome	2.09e-05	0.00215	CbGpPWpGaD
Verapamil—ABCC10—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.01e-05	0.00207	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AGPS—acquired immunodeficiency syndrome	1.98e-05	0.00204	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AGPS—acquired immunodeficiency syndrome	1.85e-05	0.00191	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AGPS—acquired immunodeficiency syndrome	1.83e-05	0.00188	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.82e-05	0.00188	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AGPS—acquired immunodeficiency syndrome	1.78e-05	0.00183	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.71e-05	0.00176	CbGpPWpGaD
Verapamil—CACNB4—Axon guidance—IL6—acquired immunodeficiency syndrome	1.68e-05	0.00173	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	1.66e-05	0.00171	CbGpPWpGaD
Verapamil—SLC22A5—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.66e-05	0.00171	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1.66e-05	0.00171	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	1.64e-05	0.00169	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	1.64e-05	0.00169	CbGpPWpGaD
Verapamil—CACNA1I—Axon guidance—IL6—acquired immunodeficiency syndrome	1.58e-05	0.00163	CbGpPWpGaD
Verapamil—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	1.56e-05	0.00161	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	1.56e-05	0.0016	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.55e-05	0.00159	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	1.54e-05	0.00158	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.52e-05	0.00157	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	1.49e-05	0.00153	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.49e-05	0.00153	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	1.48e-05	0.00152	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	1.44e-05	0.00149	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	1.43e-05	0.00147	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.4e-05	0.00144	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.39e-05	0.00144	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.39e-05	0.00143	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	1.35e-05	0.00139	CbGpPWpGaD
Verapamil—CACNB3—Axon guidance—IL6—acquired immunodeficiency syndrome	1.34e-05	0.00138	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	1.34e-05	0.00138	CbGpPWpGaD
Verapamil—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.33e-05	0.00137	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.33e-05	0.00137	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—TAT—acquired immunodeficiency syndrome	1.33e-05	0.00137	CbGpPWpGaD
Verapamil—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	1.33e-05	0.00137	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.32e-05	0.00136	CbGpPWpGaD
Verapamil—CACNB1—Axon guidance—IL6—acquired immunodeficiency syndrome	1.31e-05	0.00135	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.3e-05	0.00134	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.24e-05	0.00128	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.23e-05	0.00126	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	1.21e-05	0.00125	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.2e-05	0.00124	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.2e-05	0.00124	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.2e-05	0.00124	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.19e-05	0.00122	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.19e-05	0.00122	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—IL6—acquired immunodeficiency syndrome	1.17e-05	0.0012	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.16e-05	0.00119	CbGpPWpGaD
Verapamil—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.14e-05	0.00118	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.13e-05	0.00116	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—IL6—acquired immunodeficiency syndrome	1.13e-05	0.00116	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.13e-05	0.00116	CbGpPWpGaD
Verapamil—SLC22A4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.12e-05	0.00116	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.08e-05	0.00111	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	1.08e-05	0.00111	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	1.08e-05	0.00111	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—TAT—acquired immunodeficiency syndrome	1.06e-05	0.00109	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	1.03e-05	0.00106	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.03e-05	0.00106	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—TNF—acquired immunodeficiency syndrome	9.98e-06	0.00103	CbGpPWpGaD
Verapamil—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	9.74e-06	0.001	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—IL6—acquired immunodeficiency syndrome	9.59e-06	0.000988	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—IL6—acquired immunodeficiency syndrome	9.58e-06	0.000987	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—IL6—acquired immunodeficiency syndrome	9.33e-06	0.000961	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AGPS—acquired immunodeficiency syndrome	8.98e-06	0.000926	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	8.94e-06	0.000922	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	8.83e-06	0.00091	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	8.78e-06	0.000905	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	8.75e-06	0.000901	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.54e-06	0.00088	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—ALB—acquired immunodeficiency syndrome	8.51e-06	0.000877	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—TNF—acquired immunodeficiency syndrome	8.47e-06	0.000873	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—ALB—acquired immunodeficiency syndrome	8.45e-06	0.000871	CbGpPWpGaD
Verapamil—SLC22A5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.44e-06	0.00087	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—IL6—acquired immunodeficiency syndrome	8.32e-06	0.000857	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—IL6—acquired immunodeficiency syndrome	8.21e-06	0.000846	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.19e-06	0.000843	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—IL6—acquired immunodeficiency syndrome	8.05e-06	0.00083	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—ALB—acquired immunodeficiency syndrome	8e-06	0.000825	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	7.98e-06	0.000823	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	7.79e-06	0.000803	CbGpPWpGaD
Verapamil—ABCC3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.78e-06	0.000802	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—IL6—acquired immunodeficiency syndrome	7.78e-06	0.000801	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	7.61e-06	0.000784	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	7.34e-06	0.000757	CbGpPWpGaD
Verapamil—ABCC4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.32e-06	0.000754	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	7.28e-06	0.00075	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—TNF—acquired immunodeficiency syndrome	7.26e-06	0.000748	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.13e-06	0.000734	CbGpPWpGaD
Verapamil—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	6.98e-06	0.00072	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—IL6—acquired immunodeficiency syndrome	6.91e-06	0.000712	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—TNF—acquired immunodeficiency syndrome	6.88e-06	0.000708	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—IL2—acquired immunodeficiency syndrome	6.85e-06	0.000706	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—IL6—acquired immunodeficiency syndrome	6.83e-06	0.000704	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—IL6—acquired immunodeficiency syndrome	6.83e-06	0.000704	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	6.79e-06	0.000699	CbGpPWpGaD
Verapamil—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.78e-06	0.000698	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	6.63e-06	0.000683	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.41e-06	0.000661	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	6.24e-06	0.000643	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	6.22e-06	0.000641	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	6.19e-06	0.000638	CbGpPWpGaD
Verapamil—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.17e-06	0.000636	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—TNF—acquired immunodeficiency syndrome	6.11e-06	0.000629	CbGpPWpGaD
Verapamil—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.1e-06	0.000628	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.1e-06	0.000628	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—TNF—acquired immunodeficiency syndrome	6.04e-06	0.000622	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—IL6—acquired immunodeficiency syndrome	5.86e-06	0.000604	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.8e-06	0.000597	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—IL6—acquired immunodeficiency syndrome	5.55e-06	0.000572	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.37e-06	0.000553	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	5.29e-06	0.000545	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.95e-06	0.00051	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—IL6—acquired immunodeficiency syndrome	4.93e-06	0.000508	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ALB—acquired immunodeficiency syndrome	4.89e-06	0.000504	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—IL6—acquired immunodeficiency syndrome	4.88e-06	0.000502	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	4.8e-06	0.000495	CbGpPWpGaD
Verapamil—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	4.79e-06	0.000493	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ALB—acquired immunodeficiency syndrome	4.66e-06	0.000481	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ALB—acquired immunodeficiency syndrome	4.63e-06	0.000477	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	4.32e-06	0.000445	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	4.08e-06	0.000421	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ALB—acquired immunodeficiency syndrome	4.07e-06	0.000419	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ALB—acquired immunodeficiency syndrome	3.8e-06	0.000392	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ALB—acquired immunodeficiency syndrome	3.75e-06	0.000386	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ALB—acquired immunodeficiency syndrome	3.65e-06	0.000376	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.5e-06	0.000361	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.17e-06	0.000327	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.13e-06	0.000322	CbGpPWpGaD
Verapamil—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	3.01e-06	0.00031	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.9e-06	0.000299	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	2.86e-06	0.000294	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.85e-06	0.000294	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	2.71e-06	0.00028	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	2.51e-06	0.000259	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	2.49e-06	0.000257	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.44e-06	0.000251	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	2.32e-06	0.000239	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	1.84e-06	0.00019	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	1.8e-06	0.000186	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	1.63e-06	0.000168	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	1.56e-06	0.000161	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	1.39e-06	0.000143	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.36e-06	0.00014	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	1.28e-06	0.000132	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	1.27e-06	0.000131	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.08e-06	0.000112	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	8.37e-07	8.63e-05	CbGpPWpGaD
